{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:39:19Z","timestamp":1761223159230,"version":"build-2065373602"},"reference-count":30,"publisher":"Danish Medical Association","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ugeskr L\u00e6ger"],"abstract":"<jats:p>In Denmark, the parathyroidectomy rate due to primary hyperparathyroidism has increased over the last decade. Primary hyperparathyroidism leads to a range of diffuse neuromuscular symptoms, bone loss and kidney stones. Tertiary hyperparathyroidism can develop in secondary hyperparathyroidism from chronic renal failure. The predominant definitive treatment for both primary and tertiary hyperparathyroidism is surgery, generally preceded by localization imaging and usually with intraoperative parathyroid hormone assessment. This publication summarizes in this review the updated management of these diseases.<\/jats:p>","DOI":"10.61409\/v05250356","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:01:56Z","timestamp":1761116516000},"page":"1-9","source":"Crossref","is-referenced-by-count":0,"title":["Surgical treatment of hyperparathyroidism"],"prefix":"10.61409","author":[{"given":"Tina Toft","family":"Kristensen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waldemar","family":"Trolle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Rolighed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Rejnmark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanja Tvistholm","family":"Sikj\u00e6r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Abrahamsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"40208","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"key":"ref0","unstructured":"Svensson HVP, Vestergaard P, Harsl\u00f8f T, et al. Prim\u00e6r hyperparathyreodisme (PHPT), 2022. https:\/\/endocrinology.dk\/nbv\/calcium-og-knoglemetabolisme\/primaer-hyperparathyreoidisme\/ (28. maj 2025)"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Bollerslev J, Rejnmark L, Zahn A, et al. European Expert Consensus on Practical Management of Specific Aspects of Parathyroid Disorders in Adults and in Pregnancy: Recommendations of the ESE Educational Program of Parathyroid Disorders. Eur J Endocrinol. 2022;186(2):R33-R63. https:\/\/doi.org\/10.1530\/EJE-21-1044","DOI":"10.1530\/EJE-21-1044"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Hannan FM, Babinsky VN, Thakker RV. Disorders of the calcium-sensing receptor and partner proteins: insights into the molecular basis of calcium homeostasis. J Mol Endocrinol. 2016;57(3):R127-42. https:\/\/doi.org\/10.1530\/JME-16-0124","DOI":"10.1530\/JME-16-0124"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Arjunan D, Minisola S, Rao SD, Bhadada SK. Changing trends in clinical presentation of primary hyperparathyroidism across countries over time. Best Pract Res Clin Endocrinol Metab. 2025;39(2):101980. https:\/\/doi.org\/10.1016\/j.beem.2025.101980 (19. maj 2025)","DOI":"10.1016\/j.beem.2025.101980"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Silverberg SJ, Shane E, Jacobs TP, et al. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med. 1999;341(17):1249-55. https:\/\/doi.org\/10.1056\/NEJM199910213411701","DOI":"10.1056\/NEJM199910213411701"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Rejnmark L, Vestergaard P, Mosekilde L. Nephrolithiasis and renal calcifications in primary hyperparathyroidism. J Clin Endocrinol Metab. 2011;96(8):2377-85. https:\/\/doi.org\/10.1210\/jc.2011-0569","DOI":"10.1210\/jc.2011-0569"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Bilezikian JP, Khan AA, Silverberg SJ, et al. Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop. J Bone Miner Res. 2022;37(11):2293-2314. https:\/\/doi.org\/10.1002\/jbmr.4677","DOI":"10.1002\/jbmr.4677"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"English KA, Lines KE, Thakker RV. Genetics of hereditary forms of primary hyperparathyroidism. Hormones (Athens). 2024;23(1):3-14. https:\/\/doi.org\/10.1007\/s42000-023-00508-9","DOI":"10.1007\/s42000-023-00508-9"},{"key":"ref8","unstructured":"Abood A, Vestergaard P. Increasing incidence of primary hyperparathyroidism in Denmark. Dan Med J. 2013;60(2):A4567"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Soto-Pedre E, Newey PJ, Leese GP. Stable incidence and increasing prevalence of primary hyperparathyroidism in a population-based study in Scotland. J Clin Endocrinol Metab. 2023;108(10):e1117-24. https:\/\/doi.org\/10.1210\/clinem\/dgad201","DOI":"10.1210\/clinem\/dgad201"},{"key":"ref10","unstructured":"Sundhedsdatastyrelsen. Data og registre. www.sundhedsdatastyrelsen.dk\/data-og-registre (31. mar 2025)"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Krakauer M, Wieslander B, Myschetzky PS, et al. A prospective comparative study of parathyroid dual-phase scintigraphy, dual-isotope subtraction scintigraphy, 4D-CT, and ultrasonography in primary hyperparathyroidism. Clin Nucl Med. 2016;41(2):93-100. https:\/\/doi.org\/10.1097\/RLU.0000000000000988","DOI":"10.1097\/RLU.0000000000000988"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Christensen JW, Ismail A, Sondergaard SB, et al. Preoperative imaging in primary hyperparathyroidism: Are (11)C-choline PET\/CT and (99m)Tc-MIBI\/(123)iodide subtraction SPECT\/CT interchangeable or do they supplement each other? Clin Endocrinol (Oxf). 2022;97(3):258-267. https:\/\/doi.org\/10.1111\/cen.14688","DOI":"10.1111\/cen.14688"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Michaelsen SH, Bay M, Gerke O, et al. Evaluation of surgeon-performed ultrasonography with or without contrast enhancement vs scintigraphy in patients with primary hyperparathyroidism. JAMA Otolaryngol Head Neck Surg. 2023;149(6):531-9. https:\/\/doi.org\/10.1001\/jamaoto.2023.0389","DOI":"10.1001\/jamaoto.2023.0389"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Kim DH, Lee S, Jung J, et al. Near-infrared autofluorescence-based parathyroid glands identification in the thyroidectomy or parathyroidectomy: a systematic review and meta-analysis. Langenbecks Arch Surg. 2022;407(2):491-9. https:\/\/doi.org\/10.1007\/s00423-021-02269-8","DOI":"10.1007\/s00423-021-02269-8"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Perrier N, Lang BH, Farias LCB, et al. Surgical aspects of primary hyperparathyroidism. J Bone Miner Res. 2022;37(11):2373-90. https:\/\/doi.org\/10.1002\/jbmr.4689","DOI":"10.1002\/jbmr.4689"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Flynn MB, Quayyum M, Goldstein RE, Bumpous JM. Outpatient parathyroid surgery: ten-year experience: is it safe? Am Surg. 2015;81(5):472-7. https:\/\/doi.org\/10.1177\/000313481508100528","DOI":"10.1177\/000313481508100528"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Randolph GW, Dralle H, Abdullah H, et al; International Intraoperative Monitoring Study Group. Electrophysiologic recurrent laryngeal nerve monitoring during thyroid and parathyroid surgery: international standards guideline statement. Laryngoscope. 2011;121(Suppl 1):S1-16. https:\/\/doi.org\/10.1002\/lary.21119","DOI":"10.1002\/lary.21119"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Quinn AJ, Ryan EJ, Garry S, et al. Use of intraoperative parathyroid hormone in minimally invasive parathyroidectomy for primary hyperparathyroidism: a systematic review and meta-analysis. JAMA Otolaryngol Head Neck Surg. 2021;147(2):135-43. https:\/\/doi.org\/10.1001\/jamaoto.2020.4021","DOI":"10.1001\/jamaoto.2020.4021"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Madsen AR, Rasmussen L, Godballe C. Risk factors for treatment failure in surgery for primary hyperparathyroidism: the impact of change in surgical strategy and training procedures. Eur Arch Otorhinolaryngol. 2016;273(6):1599-605. https:\/\/doi.org\/10.1007\/s00405-015-3678-6","DOI":"10.1007\/s00405-015-3678-6"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Castellano E, Benso P, Attanasio R, et al. Surgical approach to primary hyperparathyroidism in patients with concomitant thyroid diseases: a retrospective single center study. Int J Endocrinol. 2020;2020:2182539. https:\/\/doi.org\/10.1155\/2020\/2182539","DOI":"10.1155\/2020\/2182539"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Allendorf J, DiGorgi M, Spanknebel K, et al. 1112 consecutive bilateral neck explorations for primary hyperparathyroidism. World J Surg. 2007;31(11):2075-80. https:\/\/doi.org\/10.1007\/s00268-007-9068-5","DOI":"10.1007\/s00268-007-9068-5"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Zaman M, Raveendran L, Senay A, et al. Long-term recurrence rates after surgery in primary hyperparathyroidism. J Clin Endocrinol Metab. 2023;108(11):3022-30. https:\/\/doi.org\/10.1210\/clinem\/dgad316","DOI":"10.1210\/clinem\/dgad316"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Almquist M, Isaksson E, Clyne N. The treatment of renal hyperparathyroidism. Endocr Relat Cancer. 2020;27(1):R21-R34. https:\/\/doi.org\/10.1530\/ERC-19-0284","DOI":"10.1530\/ERC-19-0284"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl (2011). 2017;7(1):1-59. https:\/\/doi.org\/10.1016\/j.kisu.2017.04.001","DOI":"10.1016\/j.kisu.2017.04.001"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Baugh KA, Yip L, Ramonell KM, et al. Outcomes of subtotal parathyroidectomy for renal hyperparathyroidism. Surgery. 2024;175(3):788-93. https:\/\/doi.org\/10.1016\/j.surg.2023.09.016","DOI":"10.1016\/j.surg.2023.09.016"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Rodrigo JP, Hernandez-Prera JC, Randolph GW, et al. Parathyroid cancer: an update. Cancer Treat Rev. 2020;86:102012. https:\/\/doi.org\/10.1016\/j.ctrv.2020.102012","DOI":"10.1016\/j.ctrv.2020.102012"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Roser P, Leca BM, Coelho C, et al. Diagnosis and management of parathyroid carcinoma: a state-of-the-art review. Endocr Relat Cancer. 2023;30(4):e220287. https:\/\/doi.org\/10.1530\/ERC-22-0287","DOI":"10.1530\/ERC-22-0287"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Schini M, Jacques RM, Oakes E, et al. Normocalcemic hyperparathyroidism: study of its prevalence and natural history. J Clin Endocrinol Metab. 2020;105(4):e1171-86. https:\/\/doi.org\/10.1210\/clinem\/dgaa084","DOI":"10.1210\/clinem\/dgaa084"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Chander NR, Chidambaram S, van Den Heede K, et al. Correlation of preoperative imaging findings and parathyroidectomy outcomes support NICE 2019 guidance. J Clin Endocrinol Metab. 2022;107(3):e1242-e1248. https:\/\/doi.org\/10.1210\/clinem\/dgab740","DOI":"10.1210\/clinem\/dgab740"}],"container-title":["Ugeskrift for L\u00e6ger"],"original-title":[],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:08:59Z","timestamp":1761221339000},"score":1,"resource":{"primary":{"URL":"https:\/\/ugeskriftet.dk\/videnskab\/V05250356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":30,"URL":"https:\/\/doi.org\/10.61409\/v05250356","relation":{},"ISSN":["0041-5782","1603-6824"],"issn-type":[{"type":"print","value":"0041-5782"},{"type":"electronic","value":"1603-6824"}],"subject":[],"published":{"date-parts":[[2025,10,13]]}}}